相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pexidartinib Provides Modest Pain Relief in Patients With Tenosynovial Giant Cell Tumor: Results From ENLIVEN
John H. Healey et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2023)
Treatment updates on tenosynovial giant cell tumor
Emanuela Palmerini et al.
CURRENT OPINION IN ONCOLOGY (2022)
A prospective real-world study of the diffuse-type tenosynovial giant cell tumor patient journey: A 2-year observational analysis
Nicholas M. Bernthal et al.
JOURNAL OF SURGICAL ONCOLOGY (2022)
Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trial
Michiel van de Sande et al.
ACTA ORTHOPAEDICA (2021)
The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey: a prospective multicenter study
Nicholas M. Bernthal et al.
ORPHANET JOURNAL OF RARE DISEASES (2021)
Unravelling the heterogeneity of soft tissue and bone sarcoma patients' health-related quality of life: a systematic literature review with focus on tumour location
Dide den Hollander et al.
ESMO OPEN (2020)
Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee?
Monique J. L. Mastboom et al.
HISTOPATHOLOGY (2019)
The effect of surgery in tenosynovial giant cell tumours as measured by patient-reported outcomes on quality of life and joint function
F. G. M. Verspoor et al.
BONE & JOINT JOURNAL (2019)
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial
William D. Tap et al.
LANCET (2019)
The measurement of physical functioning among patients with Tenosynovial Giant Cell Tumor (TGCT) using the Patient-Reported Outcomes Measurement Information System (PROMIS)
Heather L. Gelhorn et al.
JOURNAL OF PATIENT-REPORTED OUTCOMES (2019)
Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial
Hans Gelderblom et al.
LANCET ONCOLOGY (2018)
Clinical characteristics and treatment outcomes in six cases of malignant tenosynovial giant cell tumor: initial experience of molecularly targeted therapy
Robert Nakayama et al.
BMC CANCER (2018)
Tenosynovial Giant Cell Tumor: Incidence, Prevalence, Patient Characteristics, and Recurrence. A Registry-based Cohort Study in Denmark
Vera Ehrenstein et al.
JOURNAL OF RHEUMATOLOGY (2017)
Colony-Stimulating Factor 1 Receptor Blockade Inhibits Tumor Growth by Altering the Polarization of Tumor-Associated Macrophages in Hepatocellular Carcinoma
Jian-Yang Ao et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
Michael A. Cannarile et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Higher incidence rates than previously known in tenosynovial giant cell tumors A nationwide study in The Netherlands
Monique J. L. Mastboom et al.
ACTA ORTHOPAEDICA (2017)
Patient-reported Symptoms of Tenosynovial Giant Cell Tumors
Heather L. Gelhorn et al.
CLINICAL THERAPEUTICS (2016)
Current Systemic Treatment Options for Tenosynovial Giant Cell Tumor/Pigmented Villonodular Synovitis: Targeting the CSF1/CSF1R Axis
Mehdi Brahmi et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2016)
Diffuse-type tenosynovial giant cell tumour: Current treatment concepts and future perspectives
Eric L. Staals et al.
EUROPEAN JOURNAL OF CANCER (2016)
Tenosynovial giant cell tumour/pigmented villonodular synovitis: Outcome of 294 patients before the era of kinase inhibitors
Emanuela Palmerini et al.
EUROPEAN JOURNAL OF CANCER (2015)
Long-term follow-up results of primary and recurrent pigmented villonodular synovitis
Floortje G. M. Verspoor et al.
RHEUMATOLOGY (2014)
Functional outcome and quality of life after the surgical treatment for diffuse-type giant-cell tumour around the knee
L. van der Heijden et al.
Bone & Joint Journal (2014)
A multidisciplinary approach to giant cell tumors of tendon sheath and synoviumA critical appraisal of literature and treatment proposal
Lizz van der Heijden et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
The management of diffuse-type giant cell tumour (pigmented villonodular synovitis) and giant cell tumour of tendon sheath (nodular tenosynovitis)
L. van der Heijden et al.
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME (2012)
Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis
Vinod Ravi et al.
CURRENT OPINION IN ONCOLOGY (2011)
Pigmented Villonodular Synovitis: A Retrospective Single-Center Study of 122 Cases and Review of the Literature
Sebastien Ottaviani et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2011)
Outcomes after Excision of Pigmented Villonodular Synovitis of the Knee
Vivek Sharma et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2009)
From the archives of the AFIP - Pigmented villonodular synovitis: Radiologic-pathologic correlation
Mark D. Murphey et al.
RADIOGRAPHICS (2008)
What affects the recurrence and clinical outcome of pigmented villonodular synovitis?
Catharina Chiari et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2006)
分享论文
